14th Oct 2013 13:01
LONDON (Alliance News) - GlaxoSmithKline PLC said Monday that President of Pharmaceuticals Research and Development, Patrick Vallance, had increased his shareholding by 143 shares after he reinvested his dividend and bought shares via his connected person on October 3 and 4.
Shares were purchased a price of 1561.8039 pence each. GlaxoSmithKline did not provide details of how many shares were purchased.
Shares in the pharmaceutical company were trading up 1.35 pence at 1,555.85 pence Monday afternoon.
By Hana Stewart-Smith; [email protected]; @hanassallnews
Copyright 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Glaxosmithkline